Algo version: 0.98b
HRMY is listed at the NASDAQ Exchange
HRMY [HRMY]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is HRMY stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Harmony Biosciences 10 years ago, but if you had invested on Wednesday 19th of August 2020 when the price was $37.01, you would have made a loss of $-4.17 per share or -11.27%

Yes, the average daily trading liquidity for Harmony Biosciences is $20.80 million. You should therefore be able to get in and out of your positions relatively fast.

Harmony Biosciences has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.21, the company's ability to pay off the debt is good. Harmony Biosciences has a good net profit margin of 17.98% and should have high tolerances against inflation.

We have calculated the inflation risk for Harmony Biosciences to be low [0.25 out of 1]